Stockreport

SAB Biotherapeutics to Present at the BIO CEO & Investor Conference [Yahoo! Finance]

SAB Biotherapeutics, Inc.  (SABS) 
PDF biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression o [Read more]